^
over1year
A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
P1, N=50, Not yet recruiting, Qilu Pharmaceutical Co., Ltd.
New P1 trial • Metastases
|
HER-2 (Human epidermal growth factor receptor 2)
|
QLS12004